Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Alzheimer's & Dementia, 2024
Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease

Quesnel M., Labonté A., Picard C. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationCSF

CNS Neuroscience & Therapeutics, 2024
Shared genetics and causal association between plasma levels of SARSCoV‐2 entry receptor ACE2 and Alzheimer's disease

Zhang Y., Xu F., Wang T. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2024
Immune cell topography of head and neck cancer

Muijlwijk T., Nijenhuis D., Ganzevles S. et al.

Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024
Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms

Villikudathil A., Mc Guigan D., English A.

Olink Target 96Metabolic DiseasesPatient StratificationData SciencePlasma

Nature Communications, 2024
Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants

Shetty N., Gaonkar M., Patel N. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

ESC Heart Failure, 2024
Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Qayyum A., Frljak S., Juhl M. et al.

Olink Target 96CVDPathophysiologyPlasma

ESC Heart Failure, 2024
IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure

Baumhove L., van Essen B., Dokter M. et al.

Olink Target 96CVDPathophysiologySerum

Journal of Proteome Research, 2024
Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression

Yu S., Yang L., Shu J. et al.

Olink Target 96OncologyPathophysiologyPatient StratificationTissue Lysate

Archives of Dermatological Research, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo

Yamaguchi Y., Peeva E., Duca E. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Clinical Cancer Research, 2024
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

Reinmuth N., Juan-Vidal O., Kowalski D. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Journal of Endocrinological Investigation, 2024
Serum proteome signatures associated with liver steatosis in adolescents with obesity

Giraudi P., Pascut D., Banfi C. et al.

Olink Target 96Metabolic DiseasesHepatologyPatient StratificationSerum

Journal of Proteome Research, 2024
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis

Monedeiro F., Ehall B., Tiffner K. et al.

Olink Target 48Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasmaInterstitial Fluid

Critical Care Explorations, 2024
Can Biomarkers Correctly Predict Ventilator-associated Pneumonia in Patients Treated With Targeted Temperature Management After Cardiac Arrest? An Exploratory Study of the Multicenter Randomized Antibiotic (ANTHARTIC) Study

Deye N., Le Gouge A., François B. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Journal of Investigative Dermatology, 2024
Dermal white adipose tissue derived IL-33 regulates interleukin 4/13 expression in myeloid cells during inflammation

Ertel A., Anderegg U., Franz S. et al.

Olink Target 48 MouseImmunological & Inflammatory DiseasesTissue Culture Conditioned Medium

Clinical Immunology, 2024
Targeted serum proteome profiling reveals nicotinamide adenine dinucleotide phosphate (NADPH)-related biomarkers to discriminate linear IgA bullous disorder from dermatitis herpetiformis

Wang T., Li L., Cao S. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPatient StratificationSerum

Science, 2024
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients

Mathew D., Marmarelis M., Foley C. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Medicine, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Horwitz S., Nirmal A., Rahman J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Journal of Proteome Research, 2024
Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19

Gong Q., Fu M., Wang J. et al.

Olink Target 96Infectious DiseasesOphthalmologyPathophysiologyAqueous Humor

European Heart Journal: Acute Cardiovascular Care, 2024
Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit

Patel S., Lopes M., Morrow D. et al.

Olink Target 96CVDPatient StratificationBlood

Frontiers in Immunology, 2024
The predictive value of TNF family for pulmonary tuberculosis: a pooled causal effect analysis of multiple datasets

Mo W., Cui Z., Zhao J. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

3478 publications